Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Pharmaceuticals Markets Breaking News: Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Biotech and Pharmaceuticals Healthy Returns Novo Nordisk A/S
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Alphabet Inc
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Government and politics Voting Ibex Ltd
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Personal finance Employee benefits Business News
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Business News Novo Nordisk A/S Biotechnology
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Tegna Inc Novo Nordisk A/S Investment strategy
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags AI / Artificial Intelligence Pharmaceuticals Investing
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Mobile Breaking News: Technology Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health care industry Eli Lilly and Co Health & Science
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Health care industry Health AstraZeneca PLC
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Health & Science Business Health care industry
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Novo Nordisk A/S Breaking news Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Health care industry Alphabet Inc Social issues
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Health & Science Apple Inc Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Health care industry Pharmaceuticals Amgen Inc
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Pharmaceuticals Amgen Inc Companies
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Earnings Business News Biotechnology
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Pharmaceuticals Novo Nordisk A/S Earnings
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Breaking News: Politics Social issues Health & Science
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Politics Health care industry Social issues
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Business Health & Science Social issues
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Wendys Co Sweetgreen Inc Constellation Brands Inc
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Biotechnology Novo Nordisk A/S Business News
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Science Novo Nordisk A/S Breaking news
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Biotechnology Business News US: News
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags US: News Business News Biotechnology
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags US: News Novo Nordisk A/S Business News
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Health & Science Eli Lilly and Co Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.